Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
An easy reference to world market indices names, with notes on regional coverage and how to recognize key benchmarks in discussions.
28,329 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Two tech giants define growth storytelling in 2026: one leads cloud security, the other powers AI infrastructure. Thi...
Oil hovers near $70 a barrel as U.S.-Iran tensions flare, signaling a risk premium for energy and a wait-and-see stan...
A top NBA star reveals a stake in a prediction market, igniting debates over ethics and the future of sports betting ...
As investment pours into Grand Rapids, the city could become a regional magnet for jobs, housing, and business growth...
MemeCore completed its second-stage upgrade, slashing gas fees and enabling smoother on-chain activity. The move spar...
Delta Air Lines CEO Ed Bastian discarded an AI-generated commencement draft and rewrote his address by hand, arguing ...
A retiree watched a $1.2m portfolio fall $187,000 in three weeks amid volatile markets. Experts say a bond sleeve cou...
As mortgage costs stay elevated, Opendoor racked up another quarterly loss. Forget opendoor technologies: this turns ...
On June 17, US spot Bitcoin ETFs flipped to net red, with total outflows of $82.2 million. The day highlighted a clea...
Tesla and BYD diverge in 2026 as margin expansion and AI investments clash with export growth and battery integration...
A rising domestic memory player is lining up a major public listing to challenge established DRAM leaders. Investors ...